Abstract 2452: Proteomic aging biomarkers predict survival in immunotherapy-treated tumors
Michal Harel, Adam P. Dicker(Thomas Jefferson University Hospital), Surbhi Singhal(International Society of Nephrology), Yehonatan Elon, Coren Lahav, M. Austin Argentieri(Broad Institute)
Cited by 0
Related Papers
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
|Journal of Clinical Oncology|2015|903
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
|Journal of Clinical Oncology|2016|654
Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations
|Nature Medicine|2024|296
Epigenetic Pathways in Human Disease: The Impact of DNA Methylation on Stress-Related Pathogenesis and Current Challenges in Biomarker Development
|EBioMedicine|2017|194
Attendance at Religious Services, Prayer, Religious Coping, and Religious/Spiritual Identity as Predictors of All-Cause Mortality in the Black Women's Health Study
|American Journal of Epidemiology|2016|174